Use of biomarkers and surrogate endpoints in health technology assessment (HTA): efficient decision-making for allocation of pharmacological treatment

在卫生技术评估（HTA）中使用生物标志物和替代终点：药物治疗分配的有效决策

• 批准号: 2486471
• 金额: --
• 依托单位: University of Leicester
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2486471
• 关键词: Use; biomarkers; surrogate; endpoints; health

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

目前，所有资助研究的摘要都不能在GTR中找到。这通常是因为在提交提案时并不需要摘要，但可能是因为它包含了个人详细信息等敏感信息。

项目成果

The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status.

• DOI: 10.3390/cancers14215391
• 发表时间: 2022-11-01
• 期刊: CANCERS
• 影响因子: 5.2
• 作者: Poad, Heather;Khan, Sam;Wheaton, Lorna;Thomas, Anne;Sweeting, Michael;Bujkiewicz, Sylwia
• 通讯作者: Bujkiewicz, Sylwia

Conference Poster: Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer

会议海报：探索治疗作用机制对转移性结直肠癌无进展生存期和总生存期之间替代关系的影响

• 发表时间: 2022
• 作者: Poad H

PCN285 Surrogate Endpoints in Advanced Colorectal Cancer in Subgroups of Patients Defined By the KRAS Biomarker Status

由 KRAS 生物标志物状态定义的晚期结直肠癌患者亚组中的 PCN285 替代终点

• DOI: 10.1016/j.jval.2020.08.422
• 发表时间: 2020
• 期刊: Value in Health
• 影响因子: 4.5
• 作者: Poad H

Conference poster

会议海报

• 发表时间: 2013
• 期刊: AGU Fall Meeting
• 作者: Penna NT